NCT07420595

Brief Summary

Stroke is a leading cause of long-term disability and death worldwide, with chronic survivors often experiencing gait disturbances (affecting up to 80%), reduced physical activity, and cardiometabolic comorbidities like obesity and hypertension. These increase risks of recurrent events and diminish quality of life. Electromechanically assisted gait training (EAGT) provides high-intensity, repetitive practice, while conventional gait training (CGT) enhances real-world functional transfer. Evidence gaps exist in the optimal sequencing of these approaches for concurrent improvements in weight management, blood pressure (BP), and mobility, particularly in high-risk chronic stroke populations. This multicenter RCT addresses these gaps by evaluating a sequenced hybrid protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable cardiovascular-diseases

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 4, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 19, 2026

Completed
Last Updated

February 19, 2026

Status Verified

February 1, 2026

Enrollment Period

3.4 years

First QC Date

February 4, 2026

Last Update Submit

February 11, 2026

Conditions

Keywords

strokestroke sequelae

Outcome Measures

Primary Outcomes (1)

  • Primary outcome

    10 meter walk test to measure functional mobility

    Baseline, 6 weeks, 12 weeks

Secondary Outcomes (1)

  • Secondary outcome

    3-month follow-up

Study Arms (3)

Group A (Hybrid: EAGT → CGT)

ACTIVE COMPARATOR

Weeks 1-6: EAGT (exoskeleton/end-effector devices; 30- 50% body-weight support, speed 1.5-2 km/h, ≥800-1200 steps/session). Weeks 7-12: CGT (overground walking, obstacles, stairs, dual-tasks).

Other: Weeks 1-6: EAGT (exoskeleton/end-effector devices; 30- 50% body-weight support, speed 1.5-2 km/h, ≥800-1200 steps/session). Weeks 7-12: CGT (overground walking, obstacles, stairs, dual-tasks).Other: Full 12 weeks CGT, progressing complexity and demands.

Group B (EAGT-only):

ACTIVE COMPARATOR

Full 12 weeks EAGT, progressing parameters for intensity.

Other: Weeks 1-6: EAGT (exoskeleton/end-effector devices; 30- 50% body-weight support, speed 1.5-2 km/h, ≥800-1200 steps/session). Weeks 7-12: CGT (overground walking, obstacles, stairs, dual-tasks).Other: Full 12 weeks CGT, progressing complexity and demands.

Group C (CGT-only)

ACTIVE COMPARATOR

Full 12 weeks CGT, progressing complexity and demands.

Other: Weeks 1-6: EAGT (exoskeleton/end-effector devices; 30- 50% body-weight support, speed 1.5-2 km/h, ≥800-1200 steps/session). Weeks 7-12: CGT (overground walking, obstacles, stairs, dual-tasks).Other: Full 12 weeks CGT, progressing complexity and demands.

Interventions

already mentioned

Also known as: Full 12 weeks EAGT, progressing parameters for intensity.
Group A (Hybrid: EAGT → CGT)Group B (EAGT-only):Group C (CGT-only)

Group C (CGT-only)

Group A (Hybrid: EAGT → CGT)Group B (EAGT-only):Group C (CGT-only)

Eligibility Criteria

Age45 Years - 78 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ischemic/hemorrhagic stroke ≥6 months prior
  • Functional Ambulation Category (FAC) ≥3; BMI ≥25 kg/m²; systolic BP ≥130 mmHg.
  • able to provide informed consent

You may not qualify if:

  • Unstable cardiovascular conditions
  • Severe cognitive impairment (MMSE \<20)
  • Other neurological disorders affecting gait
  • Musculoskeletal issues limiting training

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IQRA National University

Swat, Peshawar, Pakistan

Location

Related Links

MeSH Terms

Conditions

Cardiovascular DiseasesStroke

Interventions

Calcium Carbonate

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Calcium CompoundsInorganic ChemicalsCarbonatesCarbonic AcidCarbon Compounds, InorganicMinerals

Study Officials

  • Ayman Abdullah Alhammad

    Taibah University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, assessor-blinded, three-arm parallel-group RCT Allocation: 1:1:1 Duration: 12 weeks intervention + 3-month follow-up (total 6 months) Setting: Five rehabilitation centers in Pakistan (e.g., Swat Psychiatric Care \& Rehabilitation Center, Al-Makki Rehabilitation Center, Hashoo Foundation Rehabilitation Center, Model Addiction Treatment \& Rehabilitation Centre - Swat, and one additional site).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 4, 2026

First Posted

February 19, 2026

Study Start

January 1, 2022

Primary Completion

June 1, 2025

Study Completion

December 1, 2025

Last Updated

February 19, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

due to ethical considerations as per ethical approval document

Locations